Pharmaxis Announces Two-Tranche Placement to Raise A$10 Million
19th
Oct 22
Release Date: 19/10/2022 9:00am
- A$10.0 million two-tranche placement to a small group of international and domestic institutional investors.
- A$30m pro-forma cash balance post raising.
- Funds raised will be used to advance the Company’s current clinical study in myelofibrosis, other clinical studies in or close to recruitment in scarring, liver cancer and Parkinson’s disease.
- Placement announced in conjunction with positive interim data from Myelofibrosis Phase 2 cancer trial. Refer separate announcement dated 19 October 2022.
Categories: News and Media